Loading...
OTCM
CPMD
Market cap1mUSD
Jul 21, Last price  
0.00USD
1D
0.00%
1Q
-31.82%
Jan 2017
-99.25%
Name

CannaPharmaRx Inc

Chart & Performance

D1W1MN
OTCM:CPMD chart
No data to show
P/E
P/S
2.42
EPS
Div Yield, %
Shrs. gr., 5y
82.16%
Rev. gr., 5y
%
Revenues
820k
620,000000000000000000000820,137
Net income
-10m
L
-4,750,0009,6077,113,891-201,590108,863575,404-99,661-98,067-94,406-3,978,433-11,742,932-1,001,250-6,633-3,094,306-24,924,217-22,184,130-10,339,890-8,531,0203,688,456-9,905,789
CFO
0k
P
-3,350,0000-106,828-62,483-69,123-60,000-12,104-10,913-11,017-1,541,106-2,548,759-22,3800-941,136-3,794,771-563,573-2,414,656-1,448,364-2,274,4520

Profile

CannaPharmaRX, Inc. operates in the cannabis industry in Canada. It negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.
IPO date
Oct 29, 1999
Employees
6
Domiciled in
CA
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
820
 
Cost of revenue
557
1,347
5,501
Unusual Expense (Income)
NOPBT
264
(1,347)
(5,501)
NOPBT Margin
32.14%
Operating Taxes
2,693
Tax Rate
NOPAT
264
(1,347)
(8,194)
Net income
(9,906)
-368.56%
3,688
-143.24%
(8,531)
-17.49%
Dividends
Dividend yield
Proceeds from repurchase of equity
1
20
437
BB yield
Debt
Debt current
7,977
7,200
8,931
Long-term debt
11,660
11,187
Deferred revenue
Other long-term liabilities
4,893
Net debt
3,456
14,342
20,037
Cash flow
Cash from operating activities
(2,274)
(1,448)
CAPEX
(81)
(116)
Cash from investing activities
(81)
(116)
Cash from financing activities
1,699
2,353
1,405
FCF
13,285
(510)
(9,281)
Balance
Cash
2
650
2
Long term investments
4,518
4,518
79
Excess cash
4,479
4,519
81
Stockholders' equity
(100,488)
(87,980)
(91,868)
Invested Capital
93,548
88,763
89,049
ROIC
0.29%
ROCE
195.11%
EV
Common stock shares outstanding
625,276
308,938
211,044
Price
Market cap
EV
EBITDA
264
(1,219)
(5,206)
EV/EBITDA
Interest
2,264
1,697
2,290
Interest/NOPBT
858.90%